Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

What revenue - what will be the sustaining income that will preclude more RS and AS increases

I'm sorry but maybe I missed that list

would you please repost

last time I looked the ESS trials at 3 US Army bases were discontinued

MANF is still in rat testing modality and 5 - 7 years away from human test trials

Eltopra needs to resume Ph 2 testing

Phrnoguard is in a box on the shelf

NuroPro and SeraPeo and have not been touched in a decade

I gave a link of the Chairman CEO Blogs that were all essentially missed milestones and false prognostications

So please Sir, do enlighten us as to AMBS financial self-sustaining prowess

AJMHO